Menu

Blog

Archive for the ‘bioengineering’ category: Page 8

Dec 13, 2023

Can gene editing drive out HIV and hepatitis viruses from inside cells?

Posted by in categories: bioengineering, biotech/medical, genetics

Armed with gene technologies and CAR-Ts, scientists are attempting to eliminate viruses that escape immune detection and lurk in tissues for years.

Dec 12, 2023

CRSP Stock On Wild Ride After FDA’s Historic Approval. These Gene Editing Treatments Could Be Next

Posted by in categories: bioengineering, biotech/medical

Biotech stocks could be at a major turning point after FDA approval of the first gene editing drug using CRISPR technology to treat sickle cell disease. Gove…

Dec 10, 2023

Gene editing gone wrong: Scientists accidentally create angry hamsters

Posted by in categories: bioengineering, biotech/medical, genetics

A team of scientists used gene editing to create what they thought would be a calmer rodent. Instead, the gene-edited rodents were angrier.

Dec 8, 2023

Seattle biotech hub pursues ‘DNA typewriter’ tech with $75M from tech billionaires

Posted by in categories: bioengineering, biotech/medical

A new Seattle biotech organization will be funded to the tune of $75 million to research “DNA typewriters,” self-monitoring cells that could upend our understanding of biology. The collaboration between the University of Washington, the Chan-Zuckerberg Initiative and the Allen Institute is already underway.

Called the Seattle Hub for Synthetic Biology, the joint initiative will combine the expertise of the two well-funded research outfits with that of UW Medicine, working in what UW’s Jay Shendure, scientific lead for the project, called “a new model of collaboration.”

The Hub (not to be confused with the HUB, or Husky Union Building, on UW’s campus) aims to strike a balance between a disinterested intellectual academic approach and a development-focused commercial approach. The $75 million will fund the organization for five years, with the option to renew then.

Dec 8, 2023

Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy

Posted by in categories: bioengineering, biotech/medical

These three gene therapy stocks should get huge boosts over the long term from the use of gene editing techniques to treat diseases.

Dec 4, 2023

Bio Ink Made out of Bacteria Could Be Used to 3D Print Organs

Posted by in categories: 3D printing, bioengineering, biotech/medical, bitcoin, cryptocurrencies

Good telescope that I’ve used to learn the basics: https://amzn.to/35r1jAk.
Get a Wonderful Person shirt: https://teespring.com/stores/whatdamath.
Alternatively, PayPal donations can be sent here: http://paypal.me/whatdamath.

Hello and welcome! My name is Anton I’m away for a few days due to voice issues, so enjoy this older video where we talk about the incredible invention of 3D printed bio ink that could be used to print any biological tissue (in theory). 3D printed heart anyone?

Continue reading “Bio Ink Made out of Bacteria Could Be Used to 3D Print Organs” »

Nov 29, 2023

Synthetic Biology Exclusive Offers

Posted by in categories: bioengineering, biotech/medical

Discover our selection of discounted synthetic biology tools, perfect for advancing biomedicine, cell-cultured meats, and sustainable textiles.

Nov 29, 2023

Unlocking the future: where is gene editing going next?

Posted by in categories: bioengineering, biotech/medical

In our latest feature, we explore the future of gene editing and the challenges we must overcome to harness its full potential.

Nov 29, 2023

Explore the role of CRISPR gene editing in target validation

Posted by in categories: bioengineering, biotech/medical, genetics

Target validation is a crucial step in pre-clinical drug discovery workflows that builds confidence on the identification of a genetic target as relevant to a disease. With recent advancements, CRISPR serves as a particularly powerful tool for this process, as it enables researchers to accurately modify genes and determine their function in a variety of experimental systems.

One scientist leveraging CRISPR gene editing in this way is Dr. Panos Zalmas, Head of the Open Targets Validation Lab based at the Wellcome Sanger Institute, whose work focuses on discovering and validating new putative disease targets for the development of safe and effective medicines.

In this SelectScience® interview, we speak with Zalmas to learn how he is working to improve the rate of target adoption into drug discovery pipelines across therapy areas such as oncology, neurodegeneration, and immunology and inflammation. Here, Zalmas explains the importance of gene editing in his target validation workflows and highlights how CRISPR technologies in particular are key to the success of drug discovery.

Nov 28, 2023

Patient Dies After Being Gene-Edited to Have Lower Cholesterol

Posted by in categories: bioengineering, biotech/medical, genetics

Researchers have been able to reduce dramatically the level of bad cholesterol in human subjects after injecting them with an experimental gene editing treatment, according to the science journal Nature, which is the first time this technique, called base editing, has been done on humans.

But at least one person died after receiving an infusion, prompting a round of safety concerns.

In the clinical trial, 10 subjects with congenitally high levels of bad cholesterol, aka low-density lipoprotein (LDL), were given an injection of VERVE-101, a gene-editing treatment that uses the base editing technique. This treatment then turned off the gene for the protein PCSK9, which is found in the liver and regulates LDL. High levels of LDL can lead to coronary heart disease.

Page 8 of 202First56789101112Last